Business
Press Release Aug 07 2024
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 07, 2024, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Acitretin Capsules USP, 10 mg, 17.5 mg, and 25 mg.".
About this update from Alembic Pharmaceuticals Limited
[{"type":"text","content":" Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 07, 2024, titled \"Alembic Pharmaceuticals receives USFDA Final Approval for Acitretin Capsules USP, 10 mg, 17.5 mg, and 25 mg.\". View Attachment","length":419,"tagName":"div"}]